If GLP-1 side effects like nausea are making treatment hard to stick with, you have options before giving up. The first steps are usually adjusting how you take the drug (a slower dose increase, smaller meals) or switching to a different GLP-1, since tolerability varies from one to the next. If those don’t work, non-GLP-1 medications and other approaches exist. TrimRx prescribes both semaglutide and tirzepatide and can tailor the dosing, which resolves side effects for many people. Here’s how to think it through.<\/p>\n
Most GLP-1 side effects are gastrointestinal (nausea, constipation, diarrhea) and tend to appear when starting or increasing the dose. Before switching drugs, the simplest fixes often help: increasing the dose more slowly, eating smaller and lower-fat meals, staying hydrated, and not lying down right after eating. A provider can hold you at a tolerated dose longer instead of pushing ahead, which frequently settles things.<\/p>\n
Tolerability differs between these drugs. In the SURMOUNT-5 trial<\/a> published in the New England Journal of Medicine in 2025, gastrointestinal side effects led to treatment discontinuation less often with tirzepatide (about 2.7%) than with semaglutide (about 5.6%). So if one GLP-1 is hard to tolerate, switching to another sometimes makes a real difference, and it’s worth trying before abandoning the class.<\/p>\n For some people, GLP-1 side effects persist despite adjustments and switching. Non-GLP-1 medications are then worth discussing: Contrave (bupropion-naltrexone), phentermine, and metformin work through different mechanisms and have different side effect profiles, though they generally produce less weight loss. These aren’t TrimRx’s focus, but a provider can help you weigh them.<\/p>\n It’s also worth knowing that several drugs in development, particularly amylin-based ones, have shown notably gentle gastrointestinal profiles in early trials. They aren’t available yet, so they can’t be counted on today, but tolerability is an active area of progress.<\/p>\n Consider a hypothetical patient who felt constant nausea on semaglutide and nearly quit. Restarting at a lower dose with a slower climb, or switching to tirzepatide, could make treatment manageable, which is why adjusting before abandoning the approach usually pays off. You can read an honest review of how a service handles this<\/a> if you want a sense of the process.<\/p>\n Start by slowing the dose increase, eating smaller lower-fat meals, and staying hydrated. If that doesn’t help, switching to a different GLP-1 sometimes reduces side effects. A provider can guide both steps.<\/p>\n In a head-to-head trial, tirzepatide had somewhat fewer treatment-stopping gastrointestinal effects than semaglutide, so switching can help. Non-GLP-1 drugs have different side effect profiles but usually produce less weight loss.<\/p>\n Yes. TrimRx prescribes both semaglutide and tirzepatide and can adjust the starting dose and titration pace, or switch you between them, after a licensed provider reviews your situation.<\/p>\n\n\n
\n \nOption<\/th>\n What it involves<\/th>\n Notes<\/th>\n<\/tr>\n<\/thead>\n \n Slower dose titration<\/td>\n Increase the dose more gradually<\/td>\n The most effective first step for most people<\/td>\n<\/tr>\n \n Switching GLP-1<\/td>\n Try tirzepatide instead of semaglutide, or vice versa<\/td>\n Tolerability varies; sometimes resolves the issue<\/td>\n<\/tr>\n \n Non-GLP-1 drugs<\/td>\n Contrave, phentermine, metformin<\/td>\n Different side effect profiles, usually less weight loss<\/td>\n<\/tr>\n \n Lifestyle and support<\/td>\n Diet, activity, coaching<\/td>\n Lower results alone, useful alongside<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n If GLP-1s Still Don’t Work for You<\/h3>\n
Frequently Asked Questions<\/h3>\n
What can I do if a GLP-1 makes me too nauseous?<\/h4>\n
Is there a weight-loss drug with fewer side effects?<\/h4>\n
Can TrimRx help if I can’t tolerate my current drug?<\/h4>\n